1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Global Genetic Fortune Telling Market Analysis, By Application (Value in US$ Million)
5.1. Introduction
5.2. Familial health
5.3. Development of new treatments for untreatable diseases
5.4. Direct-to-consumer genetic testing
5.5. Genetic profiling of a newborn (Genetic report cards)
5.6. Disease prediction
6. Global Genetic Fortune Telling Market Analysis, by Geography (Value in US$ Million)
6.1. Introduction
6.2. North America
6.2.1. United States
6.2.2. Canada
6.2.3. Mexico
6.3. South America
6.3.1. Brazil
6.3.2. Others
6.4. Europe
6.4.1. Germany
6.4.2. United Kingdom
6.4.3. France
6.4.4. Others
6.5. The Middle East and Africa
6.6. Asia Pacific
6.6.1. China
6.6.2. Japan
6.6.3. South Korea
6.6.4. Others
7. Competitive Environment and Analysis
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. Company Profiles
8.1. Ancestry
8.2. Helix OpCo LLC
8.3. 23andMe, Inc.
8.4. Myriad Genetics, Inc.
8.5. UK Biobank
8.6. Broad Institute
8.7. Bayer AG